360 related articles for article (PubMed ID: 28661458)
1. Adipokines in Liver Cirrhosis.
Buechler C; Haberl EM; Rein-Fischboeck L; Aslanidis C
Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28661458
[TBL] [Abstract][Full Text] [Related]
2. Splanchnic concentrations and postprandial release of visceral adipokines.
Wiest R; Moleda L; Farkas S; Scherer M; Kopp A; Wönckhaus U; Büchler C; Schölmerich J; Schäffler A
Metabolism; 2010 May; 59(5):664-70. PubMed ID: 19913846
[TBL] [Abstract][Full Text] [Related]
3. CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt.
Berres ML; Asmacher S; Lehmann J; Jansen C; Görtzen J; Klein S; Meyer C; Strunk HM; Fimmers R; Tacke F; Strassburg CP; Trautwein C; Sauerbruch T; Wasmuth HE; Trebicka J
J Hepatol; 2015 Feb; 62(2):332-9. PubMed ID: 25457205
[TBL] [Abstract][Full Text] [Related]
4. Changes in adipokines after transjugular intrahepatic porto-systemic shunt indicate an anabolic shift in metabolism.
Thomsen KL; Sandahl TD; Holland-Fischer P; Jessen N; Frystyk J; Flyvbjerg A; Grønbæk H; Vilstrup H
Clin Nutr; 2012 Dec; 31(6):940-5. PubMed ID: 22541535
[TBL] [Abstract][Full Text] [Related]
5. Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment.
Teng D; Zuo H; Liu L; Dong J; Ding L
Virol J; 2018 Oct; 15(1):151. PubMed ID: 30285813
[TBL] [Abstract][Full Text] [Related]
6. Portal vein omentin is increased in patients with liver cirrhosis but is not associated with complications of portal hypertension.
Eisinger K; Krautbauer S; Wiest R; Karrasch T; Hader Y; Scherer MN; Farkas S; Aslanidis C; Buechler C
Eur J Clin Invest; 2013 Sep; 43(9):926-32. PubMed ID: 23855493
[TBL] [Abstract][Full Text] [Related]
7. Proprotein convertase subtilisin/kexin type 9 (PCSK9) levels are not associated with severity of liver disease and are inversely related to cholesterol in a cohort of thirty eight patients with liver cirrhosis.
Feder S; Wiest R; Weiss TS; Aslanidis C; Schacherer D; Krautbauer S; Liebisch G; Buechler C
Lipids Health Dis; 2021 Jan; 20(1):6. PubMed ID: 33461570
[TBL] [Abstract][Full Text] [Related]
8. Chemokine (C-X-C motif) ligand 11 levels predict survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt.
Berres ML; Lehmann J; Jansen C; Görtzen J; Meyer C; Thomas D; Zimmermann HW; Kroy D; Schumacher F; Strassburg CP; Sauerbruch T; Trautwein C; Wasmuth HE; Trebicka J
Liver Int; 2016 Mar; 36(3):386-94. PubMed ID: 26212075
[TBL] [Abstract][Full Text] [Related]
9. Connective tissue growth factor level is increased in patients with liver cirrhosis but is not associated with complications or extent of liver injury.
Bauer S; Eisinger K; Wiest R; Karrasch T; Scherer MN; Farkas S; Aslanidis C; Buechler C
Regul Pept; 2012 Nov; 179(1-3):10-4. PubMed ID: 22960408
[TBL] [Abstract][Full Text] [Related]
10. Effects of transjugular intrahepatic portosystemic shunt treatment of patients with liver cirrhosis and portal hypertension: Case series.
Zheng D; Yu J; Li H; Gan H; Wang J; Jiang T; Ren H; Wu F
Medicine (Baltimore); 2021 Jul; 100(27):e26610. PubMed ID: 34232216
[TBL] [Abstract][Full Text] [Related]
11. Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression.
Moschen AR; Molnar C; Wolf AM; Weiss H; Graziadei I; Kaser S; Ebenbichler CF; Stadlmann S; Moser PL; Tilg H
J Hepatol; 2009 Oct; 51(4):765-77. PubMed ID: 19664840
[TBL] [Abstract][Full Text] [Related]
12. Endotoxin and tumor necrosis factor-receptor levels in portal and hepatic vein of patients with alcoholic liver cirrhosis receiving elective transjugular intrahepatic portosystemic shunt.
Trebicka J; Krag A; Gansweid S; Appenrodt B; Schiedermaier P; Sauerbruch T; Spengler U
Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1218-25. PubMed ID: 21971377
[TBL] [Abstract][Full Text] [Related]
13. Circulating Elastin Fragments Are Not Affected by Hepatic, Renal and Hemodynamic Changes, But Reflect Survival in Cirrhosis with TIPS.
Nielsen MJ; Lehmann J; Leeming DJ; Schierwagen R; Klein S; Jansen C; Strassburg CP; Bendtsen F; Møller S; Sauerbruch T; Karsdal MA; Krag A; Trebicka J
Dig Dis Sci; 2015 Nov; 60(11):3456-64. PubMed ID: 26138655
[TBL] [Abstract][Full Text] [Related]
14. Role of adipokines in cardiovascular disease.
Mattu HS; Randeva HS
J Endocrinol; 2013 Jan; 216(1):T17-36. PubMed ID: 23160967
[TBL] [Abstract][Full Text] [Related]
15. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.
Luo SH; Chu JG; Huang H; Zhao GR; Yao KC
World J Gastroenterol; 2019 Mar; 25(9):1088-1099. PubMed ID: 30862997
[TBL] [Abstract][Full Text] [Related]
16. [New approach in the interpretation of adipose tissue].
Antal M; Regöly-Mérei A
Orv Hetil; 2010 Aug; 151(31):1252-60. PubMed ID: 20656662
[TBL] [Abstract][Full Text] [Related]
17. Seminal plasma adipokine levels are correlated with functional characteristics of spermatozoa.
Thomas S; Kratzsch D; Schaab M; Scholz M; Grunewald S; Thiery J; Paasch U; Kratzsch J
Fertil Steril; 2013 Apr; 99(5):1256-1263.e3. PubMed ID: 23375204
[TBL] [Abstract][Full Text] [Related]
18. Circulating CXCL10 in cirrhotic portal hypertension might reflect systemic inflammation and predict ACLF and mortality.
Lehmann JM; Claus K; Jansen C; Pohlmann A; Schierwagen R; Meyer C; Thomas D; Manekeller S; Claria J; Strassburg CP; Trautwein C; Wasmuth HE; Berres ML; Trebicka J
Liver Int; 2018 May; 38(5):875-884. PubMed ID: 29105936
[TBL] [Abstract][Full Text] [Related]
19. No difference in portal and hepatic venous bacterial DNA in patients with cirrhosis undergoing transjugular intrahepatic portosystemic shunt insertion.
Mortensen C; Karlsen S; Grønbæk H; Nielsen DT; Frevert S; Clemmesen JO; Møller S; Jensen JS; Bendtsen F
Liver Int; 2013 Oct; 33(9):1309-15. PubMed ID: 23763259
[TBL] [Abstract][Full Text] [Related]
20. Reduced serum chemerin in patients with more severe liver cirrhosis.
Eisinger K; Krautbauer S; Wiest R; Weiss TS; Buechler C
Exp Mol Pathol; 2015 Apr; 98(2):208-13. PubMed ID: 25595667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
